HORIZON PHARMA, INC.
Profile
Company Names
HORIZON PHARMA, INC.
Addresses
520 LAKE COOK ROAD, SUITE 520, DEERFIELD, IL 60015
1033 SKOKIE BLVD, SUITE 355, NORTHBROOK, IL 60062
Phone Numbers
224-383-3000
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
2010
State Incorporated:
DELAWARE
Total Amount Raised:
$253,387,754.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2013-11-22
$150,000,000.00
$150,000,000.00
$0.00
Debt
4
2012-03-02
$65,934,397.00
$65,934,397.00
$0.00
Equity
3
2012-02-22
$32,772.00
$32,772.00
$0.00
2
2011-06-02
$637,500.00
$637,500.00
$0.00
1
2010-04-01
$36,783,085.00
$37,500,000.00
$716,915.00
Equity, Debt
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEFFREY
W.
BIRD
DIRECTOR
HUBERT
BIRNER
DIRECTOR
LOUIS
C.
BOCK
DIRECTOR
JEAN-FRANCOIS
FORMELA
DIRECTOR
ARCA BIOPHARMA, INC.
| RESOLVYX PHARMACEUTICALS, INC.
| HORIZON PHARMA, INC.
| ANNOVATION BIOPHARMA, INC.
| ARTEAUS THERAPEUTICS, LLC
| COSTIM PHARMACEUTICALS INC.
| CALORICS, INC.
| NAVITOR PHARMACEUTICALS, INC.
| INTELLIA THERAPEUTICS, INC.
| IFM THERAPEUTICS, INC.
| SPERO THERAPEUTICS, LLC
| ATLAS VENTURE FUND XI, L.P.
| IFM TRE, INC.
| ATLAS VENTURE OPPORTUNITY FUND I, L.P.
| TRANSLATE BIO, INC.
| KORRO BIO, INC.
| IFM QUATTRO, INC.
| IFM CINQUE, INC.
| IFM CONTINUA, INC.
| ATLAS VENTURE FUND XII, L.P.
| SCORPION THERAPEUTICS, INC.
| SPERO THERAPEUTICS, INC.
| ATLAS VENTURE OPPORTUNITY FUND II, L.P.
| ATLAS VENTURE FUND XIII, L.P.
| AMAGMA, INC.
| IKENA ONCOLOGY, INC.
| ANTARES THERAPEUTICS, INC.
MICHAEL
GREY
DIRECTOR
AUSPEX PHARMACEUTICALS, INC.
| ACHILLION PHARMACEUTICALS INC
| LUMENA PHARMACEUTICALS, INC.
| SELVENTA, INC.
| HORIZON PHARMA, INC.
| BALANCE THERAPEUTICS, INC.
| AMPLYX PHARMACEUTICALS, INC.
| RENEO PHARMACEUTICALS, INC.
| MIRUM PHARMACEUTICALS, INC.
| SPRUCE BIOSCIENCES, INC.
| SORRISO PHARMACEUTICALS, INC.
| PLEXIUM, INC.
JEFF
HIMAWAN
DIRECTOR
PETER
JOHANN
DIRECTOR
GINO
SANTINI
DIRECTOR
TIMOTHY
P.
WALBERT
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2013-11-22
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2012-03-02
D/A
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity, Debt
2010-04-01
D/A
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity, Debt
2010-04-01
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
